Steven Cohen Surface Oncology, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $782,062 - $1.1 Million	-121,250 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.25 - $13.82 $2.13 Million - $4.06 Million	-293,750 Reduced 70.78%	121,250 $946,000
Q4 2020 Feb 16, 2021	SELL	$6.87 - $10.48 $9.54 Million - $14.6 Million	-1,389,020 Reduced 77.0%	415,000 $3.84 Million
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $9.13 Million - $13 Million	1,804,020 New	1,804,020 $12.4 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.